These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37711410)

  • 1. Remdesivir.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Oct; 58(5):420-430. PubMed ID: 37711410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulary Drug Reviews: Terlipressin.
    Baker DE
    Hosp Pharm; 2023 Dec; 58(6):544-548. PubMed ID: 38560548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulary Drug Reviews: Nirsevimab.
    Levien TL; Baker DE
    Hosp Pharm; 2024 Apr; 59(2):138-145. PubMed ID: 38450347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baloxavir Marboxil.
    Baker DE
    Hosp Pharm; 2019 Jun; 54(3):165-169. PubMed ID: 31205326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lefamulin.
    Kozhokar L; Levien TL; Baker DE
    Hosp Pharm; 2022 Dec; 57(6):704-711. PubMed ID: 36340625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulary Drug Reviews: Brexanolone Injection.
    Levien TL; Baker DE
    Hosp Pharm; 2022 Oct; 57(5):615-621. PubMed ID: 36081541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulary Drug Review: Betrixaban.
    Baker DE
    Hosp Pharm; 2018 Feb; 53(1):29-37. PubMed ID: 29434384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lecanemab.
    Levien TL; Baker DE
    Hosp Pharm; 2024 Oct; 59(5):519-528. PubMed ID: 39318742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capivasertib.
    Hitt EM; Baker DE
    Hosp Pharm; 2024 Oct; 59(5):509-518. PubMed ID: 39318745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crizanlizumab.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Feb; 58(1):23-29. PubMed ID: 36644753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vericiguat.
    Nguyen L; Baker DE
    Hosp Pharm; 2023 Oct; 58(5):431-436. PubMed ID: 37711406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tirzepatide.
    Baker DE; Walley K; Levien TL
    Hosp Pharm; 2023 Jun; 58(3):227-243. PubMed ID: 37216078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omadacycline.
    Baker DE
    Hosp Pharm; 2019 Apr; 54(2):80-87. PubMed ID: 30923399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maribavir.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Aug; 58(4):336-344. PubMed ID: 37360201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teplizumab.
    Baker DE
    Hosp Pharm; 2023 Dec; 58(6):549-556. PubMed ID: 38560539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulary Drug Reviews: Glecaprevir/Pibrentasvir.
    Levien TL; Baker DE
    Hosp Pharm; 2018 Apr; 53(2):75-84. PubMed ID: 29581598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulary Drug Review: Rezafungin.
    Kessel B; Baker DE
    Hosp Pharm; 2024 Jun; 59(3):245-253. PubMed ID: 38764996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulary Drug Review: Odevixibat.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Apr; 58(2):125-133. PubMed ID: 36890950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulary Drug Review: Ocrelizumab.
    Ali ZK; Baker DE
    Hosp Pharm; 2017 Oct; 52(9):599-606. PubMed ID: 29276296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulary Drug Review: Belumosudil.
    Levien TL; Baker DE
    Hosp Pharm; 2022 Aug; 57(4):435-441. PubMed ID: 35898245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.